Vanda Pharmaceuticals (VNDA) Deferred Taxes (2010 - 2025)
Vanda Pharmaceuticals (VNDA) posted Deferred Taxes of $103.2 million for Q4 2025, up 1827.25% sequentially from -$6.0 million in Q3 2025, and up 5491.12% YoY from $1.8 million in Q4 2024.
Vanda Pharmaceuticals (VNDA) Deferred Taxes (2010 - 2025) Analysis & Trends
Vanda Pharmaceuticals has reported Deferred Taxes for 8 years, with the latest figure at $103.2 million in Q4 2025.
- Quarterly Deferred Taxes rose 5491.12% year-over-year to $103.2 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $89.2 million (up 735.93% YoY) and the FY2025 annual result came in at $81.4 million, up 1356.45% from the prior year.
- Deferred Taxes advanced to $103.2 million in Q4 2025 per VNDA's latest filing, from -$6.0 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $103.2 million in Q4 2025 and troughed at -$8.0 million in Q2 2025.
- A 5-year average of $4.1 million and a median of $85500.0 in 2022 frame the typical range for Deferred Taxes.
- The widest YoY moves for Deferred Taxes: up 5491.12% in 2025, down 3069.51% in 2025.
- Over 5 years, Deferred Taxes stood at $1.3 million in 2021, then plunged by 68.24% to $417000.0 in 2022, then tumbled by 1894.72% to -$7.5 million in 2023, then surged by 74.43% to -$1.9 million in 2024, then jumped by 5491.12% to $103.2 million in 2025.
- According to Business Quant data, Deferred Taxes over the past three periods registered $103.2 million, -$6.0 million, and -$8.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Vanda Pharmaceuticals | 315.57 Mn | 145.54 Mn | 46.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103.19 Mn |
| Sep 30, 2025 | -5.97 Mn |
| Jun 30, 2025 | -7.97 Mn |
| Mar 31, 2025 | -7.80 Mn |
| Dec 31, 2024 | -1.91 Mn |
| Sep 30, 2024 | -3.09 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -246,000.00 |
| Dec 31, 2023 | -7.48 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 417,000.00 |
| Sep 30, 2022 | -1.84 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 2.53 Mn |
| Jun 30, 2021 | 1.75 Mn |
| Mar 31, 2021 | 1.16 Mn |